Keyword
aMoon Fund

Antimicrobial Technology Firm Nobio Finalizes Investment by aMoon Fund and Dr. Ole Jensen

Nobio Ltd., developer of embedded, long-acting antimicrobial particle technology, today announced the closing of a $3.6 million investment by aMoon Fund and Dr. Ole Jensen. The proprietary, non-soluble Nobio particles feature high anti-microbial activity that does not involve chemical interaction…